SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641489-22-000008
Filing Date
2022-08-15
Accepted
2022-08-15 18:15:56
Documents
71
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vtvt-20220630.htm   iXBRL 10-Q 1246121
2 EX-10.1 projectg-collaborationandl.htm EX-10.1 1319102
3 EX-31.1 vtvt-20220630xexx311.htm EX-31.1 10211
4 EX-31.2 vtvt-20220630xexx312.htm EX-31.2 10425
5 EX-32.1 vtvt-20220630xexx321.htm EX-32.1 5014
6 EX-32.2 vtvt-20220630xexx322.htm EX-32.2 4981
12 vtvt-20220630_g1.jpg GRAPHIC 66244
  Complete submission text file 0001641489-22-000008.txt   7776437

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtvt-20220630.xsd EX-101.SCH 52660
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vtvt-20220630_cal.xml EX-101.CAL 49424
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtvt-20220630_def.xml EX-101.DEF 291773
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtvt-20220630_lab.xml EX-101.LAB 569949
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtvt-20220630_pre.xml EX-101.PRE 386661
65 EXTRACTED XBRL INSTANCE DOCUMENT vtvt-20220630_htm.xml XML 936771
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37524 | Film No.: 221167547
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences